Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wes Schafer is active.

Publication


Featured researches published by Wes Schafer.


Journal of Chromatography A | 2010

Systematic evaluation of new chiral stationary phases for supercritical fluid chromatography using a standard racemate library.

Zainab Pirzada; Michelle Personick; Mirlinda Biba; Xiaoyi Gong; Lili Zhou; Wes Schafer; Christian Roussel; Christopher J. Welch

A systematic approach to the evaluation of new chiral stationary phases (CSPs) for supercritical fluid chromatography (SFC) using a standard library of racemic analytes is described. A standard library of racemic analytes representing a variety of functional group classes was assembled from a mixture of proprietary and commercial compounds. The library is dispensed and stored in a convenient 96-well microplate format to facilitate ease of use, and to minimize the amount of analyte required for analysis. Automated SFC screening was performed on both established CSPs in common use, as well as a group of six recently commercialized CSPs. Screening results were archived in a structure-searchable database that allows convenient comparison of performance data to determine which CSPs shows the best performance.


Analytical Chemistry | 2014

Chromatographic Resolution of Closely Related Species in Pharmaceutical Chemistry: Dehalogenation Impurities and Mixtures of Halogen Isomers

Erik L. Regalado; Ping Zhuang; Yadan Chen; Alexey A. Makarov; Wes Schafer; Neil T. McGachy; Christopher J. Welch

In recent years, the use of halogen-containing molecules has proliferated in the pharmaceutical industry, where the incorporation of halogens, especially fluorine, has become vitally important for blocking metabolism and enhancing the biological activity of pharmaceuticals. The chromatographic separation of halogen-containing pharmaceuticals from associated isomers or dehalogenation impurities can sometimes be quite difficult. In an attempt to identify the best current tools available for addressing this important problem, a survey of the suitability of four chromatographic method development platforms (ultra high-performance liquid chromatography (UHPLC), core shell HPLC, achiral supercritical fluid chromatography (SFC) and chiral SFC) for separating closely related mixtures of halogen-containing pharmaceuticals and their dehalogenated isosteres is described. Of the 132 column and mobile phase combinations examined for each mixture, a small subset of conditions were found to afford the best overall performance, with a single UHPLC method (2.1 × 50 mm, 1.9 μm Hypersil Gold PFP, acetonitrile/methanol based aqueous eluents containing either phosphoric or perchloric acid with 150 mM sodium perchlorate) affording excellent separation for all samples. Similarly, a survey of several families of closely related halogen-containing small molecules representing the diversity of impurities that can sometimes be found in purchased starting materials for synthesis revealed chiral SFC (Chiralcel OJ-3 and Chiralpak IB, isopropanol or ethanol with 25 mM isobutylamine/carbon dioxide) as well as the UHPLC (2.1 × 50 mm, 1.8 μm ZORBAX RRHD Eclipse Plus C18 and the Gold PFP, acetonitrile/methanol based aqueous eluents containing phosphoric acid) as preferred methods.


Green Chemistry | 2009

Performance to burn? Re-evaluating the choice of acetonitrile as the platform solvent for analytical HPLC

Christopher J. Welch; Tanja Brkovic; Wes Schafer; Xiaoyi Gong

Acetonitrile is by far the preferred organic solvent for use in Reversed Phase High Performance Liquid Chromatography (RP-HPLC) today, owing to an excellent combination of physical properties of this solvent that are favorable for chromatography (viscosity, UV absorbance cutoff, boiling point). In recent years, improvements in both instrument and stationary phase technologies have greatly enhanced the performance of routine laboratory HPLC, leading to an excess of performance for many users. In this study we re-examine the choice of acetonitrile as the platform organic solvent for HPLC, addressing the question of whether greener solvents such as ethanol could potentially replace acetonitrile in some instances.


Chirality | 2013

Improved chiral SFC screening for analytical method development.

Wes Schafer; Tilak Chandrasekaran; Zainab Pirzada; Chaowei Zhang; Xiaoyi Gong; Mirlinda Biba; Erik L. Regalado; Christopher J. Welch

In this study we describe the evaluation of a recently developed supercritical fluid chromatography (SFC) instrument for automated chiral SFC method development. The greatly improved gradient dwell volume and liquid flow control of the new instrument in combination with the use of shorter columns containing smaller stationary phase particles affords chiral SFC method development that is faster and more universal than previous systems.


Chirality | 2008

Microscale HPLC enables a new paradigm for commercialization of complex chiral stationary phases

Christopher J. Welch; Myung Ho Hyun; Takateru Kubota; Wes Schafer; Frank Bernardoni; Hee Jung Choi; Naijun Wu; Xiaoyi Gong; Bruce H. Lipshutz

The small column size (0.3 mm i.d. x 15 cm) used in microscale HPLC contains only a small fraction (<1%) of the chromatographic packing material of a typical analytical HPLC column. Consequently, chromatographic stationary phases that are prohibitively expensive in conventional HPLC, owing either to synthetic complexity or costly starting materials, may become commercially viable in the microscale format. To illustrate this point, a previously described, synthetically complex, crown ether chiral stationary phase was prepared and evaluated in the microscale format, showing excellent separation of the enantiomers of underivatized amine analytes.


ACS Medicinal Chemistry Letters | 2011

Discovery of Benzodiazepine Sulfonamide-Based Bombesin Receptor Subtype 3 Agonists and Their Unusual Chirality

Ping Liu; Thomas J. Lanza; Marc D. Chioda; Carrie K. Jones; Harry R. Chobanian; Yan Guo; Linda Chang; Theresa M. Kelly; Yanqing Kan; Oksana C. Palyha; Xiao-Ming Guan; Donald J. Marsh; Joseph M. Metzger; Katie Ramsay; Sheng-Ping Wang; Alison M. Strack; Randy R. Miller; Jianmei Pang; Kathy Lyons; Jasminka Dragovic; Jian G. Ning; Wes Schafer; Christopher J. Welch; Xiaoyi Gong; Ying-Duo Gao; Viktor Hornak; Richard G. Ball; Nancy N. Tsou; Marc L. Reitman; Matthew J. Wyvratt

We report herein the discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 (BRS-3) agonists and their unusual chirality. Starting from a high-throughput screening lead, we prepared a series of BRS-3 agonists with improved potency and pharmacokinetic properties, of which compound 8a caused mechanism-based, dose-dependent food intake reduction and body weight loss after oral dosing in diet-induced obese mice. This effort also led to the discovery of a novel family of chiral molecules originated from the conformationally constrained seven-membered diazepine ring.


Bioorganic & Medicinal Chemistry | 2012

The design and synthesis of potent, selective benzodiazepine sulfonamide bombesin receptor subtype 3 (BRS-3) agonists with an increased barrier of atropisomerization.

Harry R. Chobanian; Yan Guo; Ping Liu; Thomas J. Lanza; Marc D. Chioda; Linda Chang; Theresa M. Kelly; Yanqing Kan; Oksana C. Palyha; Xiao-Ming Guan; Donald J. Marsh; Joseph M. Metzger; Katie Raustad; Sheng-Ping Wang; Alison M. Strack; Judith N. Gorski; Randy R. Miller; Jianmei Pang; Kathy Lyons; Jasminka Dragovic; Jian G. Ning; Wes Schafer; Christopher J. Welch; Xiaoyi Gong; Ying-Duo Gao; Viktor Hornak; Marc L. Reitman; Ravi P. Nargund; Linus S. Lin

Bombesin receptor subtype 3 (BRS-3) is an orphan G-protein coupled receptor expressed primarily in the hypothalamus which plays a role in the onset of both diabetes and obesity. We report herein our progress made towards identifying a potent, selective bombesin receptor subtype-3 (BRS-3) agonist related to the previously described MK-7725(1) Chobanian et al. (2012) that would prevent atropisomerization through the increase of steric bulk at the C-2 position. This would thereby make clinical development of this class of compounds more cost effective by inhibiting racemization which can occur over long periods of time at room/elevated temperature.


Chirality | 2009

Factors influencing the interconversion of a new class of dibenzodiazepine sulfonamide atropisomers

Christopher J. Welch; Xiaoyi Gong; Wes Schafer; Harry R. Chobanian; Linus S. Lin; Mirlinda Biba; Ping Liu; Yan Guo; Adam Beard

A novel family of atropisomers based on a conformationally constrained seven membered ring system is investigated using a combination of preparative chiral chromatography, circular dichroism, and other analytical techniques. The influence of structure on the rate of atropisomer interconversion was explored with a series of analogs showing a range of interconversion rates ranging from very fast (undetectable on the HPLC timescale) to very slow (half life of many days).


Journal of Chromatography A | 2016

Toward structure-based predictive tools for the selection of chiral stationary phases for the chromatographic separation of enantiomers.

Robert P. Sheridan; Wes Schafer; Patrick Piras; Kerstin Zawatzky; Edward C. Sherer; Christian Roussel; Christopher J. Welch

ChirBase, a database for the chromatographic separation of enantiomers containing more than 200,000 records compiled from the literature, was used to develop quantitative structure activity models for the prediction of which chiral stationary phase will work for the separation of a given molecule. Constructuion of QSAR models for the enantioseparation of nineteen chiral stationary phases was attempted using only analyte structural information, leading to the producton of self-consistent models in four cases. These models were tested by predicting which in-house racemic compounds would and would not be resolved on the different columns. Some degree of success was observed, but the sparseness of data within ChirBase, which contains enantioseparations for only a subset of molecules on a subset of columns under a variety of conditions may limit the creation of effective models. Augmented data sets gleaned from automated chromatographic method development systems deployed in academic and industrial research laboratories or the use of models that take other factors such as solvent composition, temperature, etc. into account could potentially be useful for the development of more robust models.


ACS central science | 2016

Expedited Selection of NMR Chiral Solvating Agents for Determination of Enantiopurity

Lu Yang; Thomas J. Wenzel; R. Thomas Williamson; Melodie Christensen; Wes Schafer; Christopher J. Welch

The use of NMR chiral solvating agents (CSAs) for the analysis of enantiopurity has been known for decades, but has been supplanted in recent years by chromatographic enantioseparation technology. While chromatographic methods for the analysis of enantiopurity are now commonplace and easy to implement, there are still individual compounds and entire classes of analytes where enantioseparation can prove extremely difficult, notably, compounds that are chiral by virtue of very subtle differences such as isotopic substitution or small differences in alkyl chain length. NMR analysis using CSAs can often be useful for such problems, but the traditional approach to selection of an appropriate CSA and the development of an NMR-based analysis method often involves a trial-and-error approach that can be relatively slow and tedious. In this study we describe a high-throughput experimentation approach to the selection of NMR CSAs that employs automation-enabled screening of prepared libraries of CSAs in a systematic fashion. This approach affords excellent results for a standard set of enantioenriched compounds, providing a valuable comparative data set for the effectiveness of CSAs for different classes of compounds. In addition, the technique has been successfully applied to challenging pharmaceutical development problems that are not amenable to chromatographic solutions. Overall, this methodology provides a rapid and powerful approach for investigating enantiopurity that compliments and augments conventional chromatographic approaches.

Collaboration


Dive into the Wes Schafer's collaboration.

Researchain Logo
Decentralizing Knowledge